Literature DB >> 8272873

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

N Stahl1, T G Boulton, T Farruggella, N Y Ip, S Davis, B A Witthuhn, F W Quelle, O Silvennoinen, G Barbieri, S Pellegrini.   

Abstract

A recently defined family of cytokines, consisting of ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), and interleukin-6 (IL-6), utilize the Jak-Tyk family of cytoplasmic tyrosine kinases. The beta receptor components for this cytokine family, gp130 and LIF receptor beta, constitutively associate with Jak-Tyk kinases. Activation of these kinases occurs as a result of ligand-induced dimerization of the receptor beta components. Unlike other cytokine receptors studied to date, the receptors for the CNTF cytokine family utilize all known members of the Jak-Tyk family, but induce distinct patterns of Jak-Tyk phosphorylation in different cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8272873     DOI: 10.1126/science.8272873

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  223 in total

1.  Cytoplasmic STAT proteins associate prior to activation.

Authors:  S Haan; M Kortylewski; I Behrmann; W Müller-Esterl; P C Heinrich; F Schaper
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 2.  Interleukin 6 and liver regeneration.

Authors:  K L Streetz; T Luedde; M P Manns; C Trautwein
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

Authors:  Claude Haan; Peter C Heinrich; Iris Behrmann
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

Review 4.  Role of the JAK/STAT signal transduction pathway in the regulation of gene expression in CNS.

Authors:  P Dell'Albani; R Santangelo; L Torrisi; V G Nicoletti; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 5.  ALR and liver regeneration.

Authors:  Rafał Pawlowski; Jolanta Jura
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

Review 6.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

7.  Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

Authors:  Antje K Kretzschmar; Michaela C Dinger; Christian Henze; Katja Brocke-Heidrich; Friedemann Horn
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 8.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Ligand-dependent and -independent activation of the transcription factor gamma RF-1 in a cell-free system.

Authors:  C A Feghali; T M Wright
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

10.  Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.

Authors:  Yutaka Takahashi; Michiko Takahashi; Nick Carpino; Shiann-Tarng Jou; Jyh-Rong Chao; Satoshi Tanaka; Yasufumi Shigeyoshi; Evan Parganas; James N Ihle
Journal:  Mol Endocrinol       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.